Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
University of California, San Francisco
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University of Iowa
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Thomas Jefferson University
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
SWOG Cancer Research Network
Mayo Clinic
University of Washington
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
The Cleveland Clinic
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
Mayo Clinic